[1]
Smith TJ,Bohlke K,Lyman GH,Carson KR,Crawford J,Cross SJ,Goldberg JM,Khatcheressian JL,Leighl NB,Perkins CL,Somlo G,Wade JL,Wozniak AJ,Armitage JO, Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Oct 1 [PubMed PMID: 26169616]
[2]
Hankey KG,Farese AM,Blaauw EC,Gibbs AM,Smith CP,Katz BP,Tong Y,Prado KL,MacVittie TJ, Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman Primates. Radiation research. 2015 Jun [PubMed PMID: 26035709]
[3]
Yang BB,Kido A, Pharmacokinetics and pharmacodynamics of pegfilgrastim. Clinical pharmacokinetics. 2011 May [PubMed PMID: 21456630]
[4]
Yang BB,Morrow PK,Wu X,Moxness M,Padhi D, Comparison of pharmacokinetics and safety of pegfilgrastim administered by two delivery methods: on-body injector and manual injection with a prefilled syringe. Cancer chemotherapy and pharmacology. 2015 Jun [PubMed PMID: 25894719]
[5]
Kosaka Y,Rai Y,Masuda N,Takano T,Saeki T,Nakamura S,Shimazaki R,Ito Y,Tokuda Y,Tamura K, Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2015 Apr [PubMed PMID: 25576433]
[6]
Kirshner JJ,McDonald MC 3rd,Kruter F,Guinigundo AS,Vanni L,Maxwell CL,Reiner M,Upchurch TE,Garcia J,Morrow PK, NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2018 Apr [PubMed PMID: 29147854]
[7]
Dadla A,Tannenbaum S,Yates B,Holle L, Delayed hypersensitivity reaction related to the use of pegfilgrastim. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2015 Dec [PubMed PMID: 24993705]
[8]
Wolff AC,Jones RJ,Davidson NE,Jeter SC,Stearns V, Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 May 20 [PubMed PMID: 16710041]
[10]
Rechner I,Brito-Babapulle F,Fielden J, Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF). The hematology journal : the official journal of the European Haematology Association. 2003 [PubMed PMID: 12692521]
[11]
Riu G,Estefanell A,Nomdedeu M,Creus N, Overdose of pegfilgrastim: case report. International journal of clinical pharmacy. 2012 Oct [PubMed PMID: 22821554]